Medicare Part D faces increased scrutiny by Centers for Medicare & Medicaid Services (CMS) in 2017, as evidenced by the introduction of appeals timeliness monitoring reviews for coverage determinations, appeals and grievances (CDAG) and prescription drug events (PDE) self-audits. In the program audits, formulary administration (FA) was largely unchanged.
In the 2017 CMS Program Audit protocols, CMS included a new universe, Part D Call Logs, for CDAG and has started Medication Therapy Management (MTM) audits.
Join Sherry Pound, principal, and Greg Miller, senior consultant with BluePeak Advisors, to help ensure your organization’s success in navigating CMS audits, in 2017 and beyond, at this informative session.
Continuing Education Credits for pharmacists and pharmacy technicians will be available for this webinar.